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1. GENERAL EXPERIMENTAL METHODS  
All solvents used were laboratory grade and were dried over appropriate 
drying agents when required. MilliQ water was used to prepare all aqueous 
solutions. Merck 230-400 mesh Kieselgel 60 was used for column 
chromatography and Merck Kieselgel 60 0.25 mm F254 precoated sheets 
were used for analytical thin layer chromatography. Chemicals were obtained 
from Sigma-Aldrich (St. Louis, MO), Alfa Aesar and Combi Blocks and used 
as received.  
2. CHARACTERISATION INSTRUMENTATION 
 
1H-NMR spectra were collected in commercially available deuterated solvents 
(Cambridge Isotope Laboratories, Cambridge, MA) on a Bruker DRX 300 or 
Bruker Ascend 400 and 500 spectrometer. 13C-NMR spectra were recorded 
on Bruker Ascend 400 and 500 spectrometers at frequencies of 100 MHz and 
125 MHz. All chemical shifts are reported in the standard δ notation of parts 
per million using the peak of the residual solvent proton signals as an internal 
reference. J values are given in Hertz.  
 Fluorescence spectroscopic measurements were performed in 20 mM 
HEPES adjusted to pH 7.4. Fluorescence measurements were collected using 
a bench top Perkin Elmer Enspire Multimode Plate Reader at 10 nm slit 
widths. 
 Low resolution ESI-MS was recorded on a Bruker Amazon SL mass 
spectrometer operating on Electrospray Ionisation (ESI). High-resolution mass 
spectrometry was performed on a Thermo LTQ Orbitrap XL Mass 
spectrometer. Samples were diluted in methanol and added to a nano-spray 
tip coated with silver before running by positive ion nano-spray. The 
instrument was configured with a mass range 150-2000 m/z, ionspray voltage 
1.4 kV and running with a resolving power of 100,000 at m/z 400. 
  
3. SYNTHESIS 
 
 
Scheme S1 Synthesis of InCCu1. (a) POCl3, DMF (b) 3-thiapentan-1-thiol, 
Na, EtOH (c) N-hydroxysuccinimide, EDC.HCl, DMF (d) 3-bromopropan-1-
amine hydrobromide, DCM, triethylamine (e) 2,3,3-trimethylindolenine (f) 2, 
EtOH.  
 
3.1. Synthesis of InCCu1 
11 and 32 were prepared according to literature procedures. 
 
4-(bis(2-((2-(ethylthio)ethyl)thio)ethyl)amino)benzaldehyde (2) 
3-Thiapentan-1-thiol was prepared according to a reported procedure and 
used without purification.3 To prepare 2, sodium metal (230 mg, 10.0 mmol) 
was cut up into small 1-2 mm pieces and dissolved in ethanol (20 mL). 3-
thiapentan-1-thiol (1.22 g, 10.0 mmol) was added to this solution and was 
stirred for 1 h under nitrogen atmosphere at 40 ºC. Then, a solution of 1 in 
DMF (5 mL) was added and the reaction mixture stirred for 3 h at 40 ºC. 
Water (50 mL) was then added, and the mixture was extracted with 
dichloromethane (3 x 50 mL). The organic fractions were combined and 
washed with water (50 mL) and brine (50 mL) sequentially. The combined 
organic extract was dried over MgSO4 and the solvent reduced by rotary 
evaporation to give viscous orange oil. The crude oil product was immediately 
purified by flash column chromatography (1:20 MeOH:DCM) to yield 2 as a 
pale orange oil (2.28 g, 55%). 1H-NMR (500 MHz, CDCl3): δ 9.73 (s, 1H), 7.73 
(d, 2H, J 9.0 Hz), 6.68 (d, 2H, J 9.0 Hz), 3.64 (t, 4H, J 7.5 Hz), 2.74 (m, 12H), 
2.55 (q, 4H, J 7.5 Hz), 1.24 (t, 6H, J 7.5 Hz) ppm. 13C-NMR (125 MHz, 
CDCl3): δ 190.1, 151.4, 132.3, 126.0, 111.0, 51.5, 32.6, 31.9, 30.9, 29.4, 26.2 
ppm. 
 
2,5-dioxopyrrolidin-1-yl 7-(diethylamino)-2-oxo-2H-chromene-3-
carboxylate (4) 
A solution of EDC.HCl (880 mg, 4.60 mmol) and N-hydroxysuccinimide (530 
mg, 4.60 mmol) was dissolved in anhydrous DMF (15 mL). A solution of 3 
(800 mg, 3 mmol) in DMF (5 mL) was added dropwise. The reaction mixture 
was stirred in darkness for 48 h at room temperature. The resulting solution 
was then poured onto ice water (150 mL) and the resulting yellow precipitate 
was filtered off by vacuum filtration to give 4 as a pale yellow solid which was 
dried in air overnight (390 mg, 35%) and used in the next step without further 
purification. 1H-NMR (200 MHz, CDCl3): δ 8.58 (s, 1H), 7.38 (d, 1H, J 9.0 Hz), 
6.64 (dd, 1H, J 9.0, 2.5 Hz), 6.46 (s, 1H), 3.48 (q, 4H, J 7.0 Hz), 2.89 (s, 4H), 
1.26 (t, 6H, J 7.0 Hz) ppm.  
 
N-(3-bromopropyl)-7-(diethylamino)-2-oxo-2H-chromene-3-carboxamide 
(5) 
4 (300 mg, 0.60 mmol) was dissolved in DCM (20 mL) with triethylamine (128 
μL, 0.90 mmol). To this solution was added 3-bromopropan-1-amine 
hydrobromide (201 mg, 0.90 mmol) and the reaction mixture was stirred 
overnight at room temperature in the dark. The solution was subsequently 
diluted with 50 mL of DCM and washed sequentially with NaHCO3 (0.2 M, 50 
mL), HCl (0.2 M, 50 mL) and brine. The organic layer was dried over MgSO4 
and the solvent was reduced by rotary evaporation to give 5 as a yellow solid 
(190 mg, 59%). 1H-NMR (400 MHz, CDCl3): δ 8.90 (s, 1H), 8.70 (s, 1H), 7.43 
(d, 1H, J 9.0 Hz), 6.65 (dd, 1H, J 9.0, 2.0 Hz), 6.50 (d, 1H, J 2.0 Hz), 3.59 (q, 
2H, J 6.5 Hz), 3.47 (m, 6H), 2.20 (quin, 2H, J 6.5 Hz), 1.25 (t, 6H, J 7.0 Hz) 
ppm. 13C-NMR (100 MHz, CDCl3): δ 163.5, 162.8, 157.7, 152.6, 148.1, 131.1, 
110.1, 110.0, 108.4, 96.6, 45.1, 38.1, 32.6, 30.8, 12.4 ppm. 
  
1-(3-(7-(diethylamino)-2-oxo-2H-chromene-3-carboxamido)propyl)-2,3,3-
trimethyl-3H-indol-1-ium (6) 
6 was prepared by heating a neat mixture of 5 (140 mg, 0.36 mmol) and 
2,3,3-trimethylindolenine (59 μL, 0.36 mmol) at 100 ºC overnight. This 
produced a dark pink solid onto which was poured ether (20 mL) and 
vigorously scraped to retrieve the solid. The resulting suspension as filtered 
and rinsed with ether and dried in air to give 6 as a dark purple solid that was 
used in the next step immediately without further characterisation or 
purification (90 mg, 53%). ESI-MS calculated 460.26 for [M+] found 460.21.  
 
InCCu1 
Compounds 2 (79 mg, 190 μmol) and 6 (88 mg, 190 μmol) were heated to 
reflux in a solution of ethanol (10 mL) overnight with MgSO4 (catalytic) under 
nitrogen atmosphere. The resulting dark purple solution was reduced by 
rotary evaporation and immediately purified by flash column chromatography 
(silica, 1% MeOH/DCM to 5% MeOH/DCM) to yield InCCu1 as a dark purple 
solid (61 mg, 41%). HR-MS found: M+, 859.3780. C47H63N4O3S4
+ requires 
859.3778. 1H-NMR (500 MHz, CDCl3): δ 8.97 (m, 1H), 8.59 (s, 1H), 8.27 )s, 
1H), 8.12 (d, 1H, J 15.0 Hz), 7.78 (d, 1H, J 15.0 Hz), 7.42 (m, 5H), 6.81 (d, 
2H, J 8.5 Hz), 6.64 (m, 1H), 6.49 (s, 1H), 4.99 (m, 2H), 3.73 (m, 6H), 3.45 (q, 
4H, J 7.0 Hz), 2.85-2.75 (m, 12H), 2.58 (q, 4H, J 7.5 Hz), 2.31 (m, 2H), 1.80 
(s, 6H), 1.25 (m, 14H) ppm. 13C-NMR (125 MHz, CDCl3): δ 179.8, 163.6, 
162.5, 157.7, 155.4, 152.6, 152.6, 147.9, 142.5, 141.1, 135.9, 131.1, 129.4, 
127.9, 123.6, 122.4, 113.3, 112.6, 110.0, 108.3, 106.8, 96.6, 51.8, 51.2, 45.1, 
44.8, 37.1, 32.8, 31.9, 29.8, 28.6, 27.7, 26.2, 14.8, 12.4 ppm. 
 
3.2. Synthesis of InC 
 
 
Scheme S2. Synthesis of control probe InC from 6 (Scheme 1). (a) 
Dimethylaminobenzaldehyde, EtOH. 
Compound 6 was prepared as for InCCu1, but in the final step was reacted 
with dimethylaminobenzaldehyde instead of 2. 6 (30 mg, 65 μmol) and N,N-
dimethylaminobenzaldehyde (9.72 mg,  65 μmol) were heated to reflux in a 
solution of ethanol (5 mL) overnight with MgSO4 (catalytic) under nitrogen 
atmosphere. The resulting dark purple solution was reduced by rotary 
evaporation and immediately purified by flash column chromatography (silica, 
DCM to 3% MeOH/DCM) to yield InC as a dark purple solid (22 mg, 57%). 
HR-MS found: M+, 591.3323. C37H43N4O3
+ requires 591.3330. 1H-NMR (500 
MHz, CDCl3): δ 9.00 (m, 1H), 8.59 (s, 1H), 8.14 (s, 1H), 8.09 (d, 2H, J 15.0 
Hz), 7.58 (d, 2H, J 15.0 Hz), 7.47-7.37 (m, 5H), 6.77 (d, 2H, J 8.5 Hz), 6.64 (d, 
1H, J 8.5 Hz), 6.48 (s, 1H), 4.90 (t, 2H, J 7.0 Hz), 3.73 (m, 2H), 3.46 (q, 4H, J 
7.0 Hz), 3.16 (s, 6H), 2.32 (m, 2H), 1.80 (s, 6H), 1.24 (m, 6H) ppm. 13C-NMR 
(75 MHz, CDCl3): δ 179.0, 162.5, 157.7, 155.4, 155.2, 152.6, 148.0, 142.2, 
141.1, 131.2, 129.3, 127.6, 122.7, 122.3, 113.1, 112.6, 112.6, 110.1, 110.1, 
108.2, 105.3, 96.5 ppm.  
 
4. FLUORESCENCE DATA COLLETION 
 
MilliQ water was used to prepare all aqueous buffers and solutions. All 
spectra were collected in HEPES buffer (20 mM, pH 7.4). Excitation of 
InCCu1 was provided at 430 nm for in vitro studies with collection from 450-
750 nm. In the titration experiments, copper was delivered in the form of 
[Cu(MeCN)4][PF6] in acetonitrile stock solution (10 mM), which was diluted 
into HEPES buffer (20 mM, pH 7.4). 
 
The binding affinity of InCCu1 to Cu(I) was measured using thiourea as a 
competitive ligand to provide buffered and extremely low concentrations of 
Cu(I) in solution as previously reported.4 The stability constants used for 
thiourea binding were taken from reported literature. 
  
5. CELLULAR EXPERIMENTS 
 
5.1. Cell culture 
All cellular studies were performed on DLD-1 cells (passage number below 
20) cultured as a monolayer at 37 ºC in 5% CO2 humidified incubator in 
advanced Dulbecco’s modified eagle medium (Adv. DMEM) supplemented 
with 2.5 mM glutamine and 2% foetal bovine serum (FBS) without antibiotics. 
Cells were regularly mycoplasma tested. 
 
5.2. Viability assay 
 
Viability was determined using the standard AlamarBlue assay. In a 96-well 
plate, approximately 1 x 104 DLD-1 cells in 100 µL complete medium (Adv. 
DMEM supplemented with FCS and glutamine) were seeded into each well 
and allowed to adhere overnight in an incubator. 2 mM stock solution of CisPt 
in PBS was used to prepare serial dilutions ranging between 0 – 0.8 mM (40% 
PBS in media). Then 10 uL of the appropriate solution was added to the wells 
containing cells to final concentrations ranging from 0 - 80 µM. Control wells 
were treated with corresponding volumes of the vehicle (40% PBS in media). 
Each treatment was performed in triplicates. After a 16 h incubation period, 
10 µL of AlamarBlue solution was added to each well and the cells were 
incubated for additional 3 h and the plates were shaken for 1 min. The 
fluorescence of each well was recorded at 590 nm using a plate reader (λex = 
570 nm). 
 
5.3.  Microscopes and software 
 
Single-photon confocal images were acquired using an Olympus FluoVIew 
FV1000 inverted light confocal microscope (single-photon images) with 
Olympus UPLanSApo 60X water-immersion objective lens (NA = 1.20). 
Excitation light at 405 nm (1% laser power) was provided by a FV5-LDPSU 
405 nm laser and Melles Griot laser was used as a source of 633 nm 
excitation light (1% laser power). Multi-photon images were acquired using a 
Leica SP5 II confocal multi-photon microscope with HC PLApoCS2 63X 
water-immersion objective lens (NA = 1.20). Excitation light of 820 nm was 
provided by the Mai Tai DeepSee™ Ti:Sapphire femtosecond pulsed laser. 
Cells were imaged directly after treatment with the probe, in a temperature-
controlled incubator at 37 ºC (on Olympus FV1000 microscope) or directly on 
the stage (on Leica SP5 II microscope). Images were collected using FV10-
ASW viewer software v1.7 (Olympus) and Leica Application Suite Advanced 
Fluorescence Version: 2.8.0 build 7266 viewer software. Image analysis was 
performed using FIJI (National Institutes of Health). 
 
5.4. Cell preparation and treatments 
 
DLD-1 cells were cultured as described above. Before each experiment, a 
stock suspension of cells in logarithmic growth phase was prepared in media 
described above and 2 mL of this suspension of cells (30 000 – 35 000 cells 
per dish) were added onto 35 mm glass-bottom dishes (MatTek Corporation) 
48 h before imaging to ensure the adherence of cells and restoration of their 
normal growth before any treatments. 
 
Cells were treated with 2 mL of supplemented media (glutamine and FBS) 
containing vehicle control (phosphate-buffered saline, PBS) or copper sulfate 
(20 µL of 10 mM stock solution of copper sulfate in PBS to the final 
concentration of 100 µM) and then washed 3 times with PBS. After the given 
incubation time, cells were washed 3 times with PBS and incubated in 1 mL 
solution of a desired concentration of InCCu1 (0.1 or 0.2 µM) in Adv. DMEM 
media (supplemented only with 2.5 mM glutamine) and prepared immediately 
before the addition to cells by diluting a 1000x concentrated stock solution of 
the probe in DMSO with the media (final concentration of DMSO in cell media 
was less than 0.1%). After 15 minutes cells were washed 3 times with PBS 
and imaged in 10 % FBS in PBS immediately after treatment.  
 
For colocalisation experiments, cells were treated firstly for 15 min with 
InCCu1 (50 nM, from a 50 µM DMSO stock solution). After washing thrice 
with PBS, cells were then treated for 15 min with MitoTracker Deep Red (100 
nM, from a 100 µM DMSO stock solution) before imaging in 10% fetal bovine 
serum (FBS) in PBS immediately after the treatment. 
 
5.5. Imaging experiments. 
 
Images were typically collected at two channels: blue channel collecting 425 – 
525 nm light and red channel collecting 570 nm – 670 nm light. 
 
Images on Olympus FV1000 microscope were collected upon excitation with 
a 405 nm laser at 1% laser power at 1024x1024 resolution applying 4x line 
averaging. Images on Leica SP5 II microscope were collected upon excitation 
with 820 nm pulsing multi-photon laser at 512x512 resolution applying 4x line 
averaging.  
 
In co-localisation experiments, images were collected on Olympus FV1000 
microscope similarly to the method described above but at three channels: 
blue channel (425 nm – 525 nm), red channel (570 nm – 620 nm) and deep 
red channel (655 nm – 755 nm), upon simultaneous excitation with 405 laser 
and 633 nm laser. At least five fields of view per sample were photographed 
and analysed on ImageJ. 
 
 
6. Flow cytometry 
 
Flow cytometric analyses were performed using BD biosciences LSRFortessa 
equipped with a 56 mW 405 nm coherent laser. Cells were cultured as 
detailed above for at least 24 h before an appropriate treatment was added in 
fresh AdvDMEM media. Treatment included vehicle (PBS) or 10 µM cisplatin 
solution prepared immediately before treatment by diluting 10 µL of 2 mM 
stock solution in PBS in 2 mL of supplemented media. After 16 h cells were 
treated additionally with vehicle (PBS) or copper sulfate (as above) for 2 h. 
Then they were washed 3 times with PBS before the addition of InCCu1 (0.2 
µM, 15 min) solution in AdvDMEM media supplemented with glutamine (2.5 
mM) but without FBS. After 15 minutes cells were washed 3 times with PBS 
prior to the addition of trypsin (5 mins) to cause detachment from the dish, 
followed by addition of cold 10 % (v/v) FBS in PBS. After centrifugation cells 
were resuspended in cold 10% (v/v) of FBS in PBS to the concentration of 
approximately 100 000 cells / mL and stored on ice prior to analysis with flow 
cytometer. Emission upon excitation at 405 nm was collected in the blue 
channel (450/50 nm) and red channel (585/15 nm). Approximately 40 000 
events were collected for each run with appropriate gating applied to isolate 
healthy and single cells according to the FSC/SSC plot. Dead cells were the 
population in the bottom-left quadrant, and constituted less than 4% of total 
cells for all treatments.  Data obtained were extracted using FlowJo software 
(Tree Star) and FlowPy (v5.2), and analysed using Microsoft Excel. 
  
  
 
 
Figure S1. The excitation and absorption spectra of InCCu1 alone and in the 
presence of Cu(I). (Left): Excitation spectra of InCCu1 (100 µM in HEPES pH 
7.4) and InCCu1 + Cu(I) (1.0 eq.) with emission at 600 nm. (Right): 
Absorbance spectra of InCCu1 (100 µM in HEPES pH 7.4) and InCCu1 + 
Cu(I) (1.0 eq).   
Figure S2. Fluorescence response of InCCu1 (100 µM in HEPES 20 mM, pH 
7.4) to increasing amounts of Cu(I), with 430 nm excitation and  emission 
collected from 450-650 nm. Ratio was determined by I450-525 / I550-650. 
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Figure S3. Reversibility of response of InCCu1 to Cu(I). The fluorescence of 
InCCu1 (100 µM in HEPES 20 mM, pH 7.4) was measured upon addition of 
Cu(I) (1.0 equivalent), and then with subsequent addition of thiourea.  
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Figure S4. Selectivity of InCCu1 for copper over metal ions. Integrated ratio 
of fluorescence response of 100 µM InCCu1 to various metals (1.0 
equivalents of each) delivered as nitrate salts (Pt was delivered in the form of 
KPtCl4 and cisplatin). Excitation provided at 430 nm, and ratio was determined 
by dividing integrated emission from 450-515 nm with 550-650 nm.  
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Figure S5. The ratio of blue to red intensity of InCCu1 with varying pH. 
Spectra were collected in HEPES buffer with InCCu1 (100 µM). Excitation 
provided at 430 nm, and ratio was determined by dividing integrated emission 
from 450-520 nm with 550-700 nm.   
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Figure S6. Intracellular emission spectrum of InCCu1. Spectral scan of DLD-
1 cells treated with InCCu1 (0.1 µM, 15 min), taken at 10 nm steps (with 10 
nm bandwidth) from 430-650 nm, with 405 nm excitation.  
  
  
 
 
Figure S7. InCCu1 localises in mitochondria. Confocal microscopy images of 
DLD-1 cells upon simultaneous excitation with 405 nm and 633 nm laser. 
Images of blue channel (λem = 420 – 520 nm) and deep red channel (λem = 
650 – 750 nm) were obtained from cells treated with MitoTracker Deep Red 
FM (100 nM, 15 min), followed by the treatment with InCCu1 (100 nM, 15 
min) Pearson’s correlation coefficient between InCCu1 and MitoTracker Deep 
Red FM is 0.96, suggesting high co-localisation. Scale bar represents 10 µm. 
 
  
  
 
 
Figure S8. InCCu1 response to changes in mitochondrial copper measured 
upon multiphoton excitation (λex = 820 nm). Ratio of mean intensities of two 
channels (channel 1 – 425 – 475 nm, channel 2 - 570 – 670 nm) from DLD-1 
cells treated with InCCu1 (200 nM, 15 min), following 16 h treatment with 
vehicle control or copper sulfate (100 µM). Error bars represent standard error 
of mean of quintuplicate measurements. 
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Figure S9. The ratio of InC emission does not respond to copper. InC (50 µM 
in HEPES 20 mM, pH 7.4) fluorescence (λex 425 nm; λem 445 – 675 nm) was 
measured alone or in the presence of copper ([Cu(MeCN)4][PF6] , 5 
equivalents). Data represents ratio of I445-525/I550-675. Error bars represent 
standard error of mean of triplicate measurements. 
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Figure S10. Cisplatin does not influence the localisation of InCCu1, but 
uncoupling the mitochondrial membrane potential with FCCP results in 
delocalisation of both probe and MitoTracker Deep Red. (Top): Confocal 
microscopy images of DLD-1 cells upon simultaneous excitation with 405 nm 
and 633 nm laser. Images of the blue channel (420-520 nm) and deep red 
channel (650-750) were obtained from cells treated with cisplatin (10 µM , 16 
h) followed by MitoTracker Deep Red (100 nM, 15 min) and then treatment 
with InCCu1 (100 nM, 15 min). (Bottom): The same cells were then treated 
with FCCP to uncouple mitochondrial oxidative phosphorylation and imaged 
again with the same lasers. Scale bars represents 10 µm. 
  
 
 
 
 
 
Figure S11. Flow cytometry reveals that cisplatin treatment compromises 
mitochondrial copper uptake. Ratio of intensities from DLD1 cells (red 
emission 585/15 / blue emission 450/50, excitation at 405 nm) for flow 
cytometric analysis of DLD-1 cells treated with InCCu1 (0.2 µM, 15 min) 
following treatment. Mean blue/red ratio for each treatment averaged for 
single and live cells. Error bars represent standard error of mean for 
quintuplicate measurements. 
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